NO884833D0 - TARGETED FORMS OF METHYL TRITIO-ANTI-TUMOR AGENTS. - Google Patents

TARGETED FORMS OF METHYL TRITIO-ANTI-TUMOR AGENTS.

Info

Publication number
NO884833D0
NO884833D0 NO884833A NO884833A NO884833D0 NO 884833 D0 NO884833 D0 NO 884833D0 NO 884833 A NO884833 A NO 884833A NO 884833 A NO884833 A NO 884833A NO 884833 D0 NO884833 D0 NO 884833D0
Authority
NO
Norway
Prior art keywords
tritio
methyl
tumor agents
targeted forms
targeted
Prior art date
Application number
NO884833A
Other languages
Norwegian (no)
Other versions
NO176480B (en
NO176480C (en
NO884833L (en
Inventor
William James Mcgahren
Martin Leon Sassiver
George A Ellestad
Phillip R Hamann
Lois M Hinman
Janis Upeslacis
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO884833D0 publication Critical patent/NO884833D0/en
Publication of NO884833L publication Critical patent/NO884833L/en
Publication of NO176480B publication Critical patent/NO176480B/en
Publication of NO176480C publication Critical patent/NO176480C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO884833A 1987-10-30 1988-10-28 Analogous Process for Preparing Targeted Forms of Methyl Tritio Anti-Tumor Agents NO176480C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11494087A 1987-10-30 1987-10-30

Publications (4)

Publication Number Publication Date
NO884833D0 true NO884833D0 (en) 1988-10-28
NO884833L NO884833L (en) 1989-05-02
NO176480B NO176480B (en) 1995-01-02
NO176480C NO176480C (en) 1995-04-12

Family

ID=22358378

Family Applications (2)

Application Number Title Priority Date Filing Date
NO884834A NO173506C (en) 1987-10-30 1988-10-28 Procedure for Preparing Disulfur Analogs of II-E33288 Anti-Tumor Agents
NO884833A NO176480C (en) 1987-10-30 1988-10-28 Analogous Process for Preparing Targeted Forms of Methyl Tritio Anti-Tumor Agents

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO884834A NO173506C (en) 1987-10-30 1988-10-28 Procedure for Preparing Disulfur Analogs of II-E33288 Anti-Tumor Agents

Country Status (19)

Country Link
EP (2) EP0313874B1 (en)
JP (2) JP2820256B2 (en)
KR (2) KR970011385B1 (en)
AR (1) AR246083A1 (en)
AT (2) ATE104309T1 (en)
AU (2) AU612714B2 (en)
BR (1) BR1100939A (en)
CA (1) CA1321582C (en)
DE (2) DE3851682T2 (en)
DK (2) DK602488A (en)
ES (2) ES2061586T3 (en)
FI (2) FI91262C (en)
HK (2) HK131897A (en)
IE (2) IE65053B1 (en)
IL (2) IL87947A (en)
NO (2) NO173506C (en)
NZ (2) NZ226727A (en)
PT (2) PT88882B (en)
ZA (2) ZA888123B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079233A (en) * 1987-01-30 1992-01-07 American Cyanamid Company N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same
US5606040A (en) * 1987-10-30 1997-02-25 American Cyanamid Company Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group
IL115770A (en) * 1989-04-14 1999-03-12 American Cyanamid Co Substituted disulfides of formula q-sp-ss-w their preparation and use for inhibiting the growth of tumours and for treating bacterial infections
GB9007384D0 (en) * 1990-04-02 1990-05-30 Duncan Ruth Coupling between polymers and other organic molecular entities utilising thiol-specific reactive groups
US5712374A (en) * 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
US5714586A (en) * 1995-06-07 1998-02-03 American Cyanamid Company Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
NZ512122A (en) 1998-11-27 2003-12-19 Darwin Discovery Ltd Compositions and methods for increasing bone mineralization
US20040009535A1 (en) 1998-11-27 2004-01-15 Celltech R&D, Inc. Compositions and methods for increasing bone mineralization
NZ511705A (en) * 2001-05-14 2004-03-26 Horticulture & Food Res Inst Methods and rapid immunoassay device for detecting progesterone and other steroids
CA2529623A1 (en) 2003-06-16 2005-02-17 Celltech R & D, Inc. Antibodies specific for sclerostin and methods for increasing bone mineralization
US8841092B2 (en) * 2006-08-30 2014-09-23 Wisconsin Alumni Research Foundation Reversible natural product glycosyltransferase-catalyzed reactions, compounds and related methods
KR100979928B1 (en) * 2008-07-16 2010-09-03 한주학 Buoyancy windmill of vertical axis type
SI3066074T1 (en) * 2013-11-04 2020-03-31 Pfizer Inc. Intermediates and methods for synthesizing calicheamicin derivatives
US11993625B2 (en) * 2017-01-24 2024-05-28 Pfizer, Inc. Calicheamicin derivatives and antibody drug conjugates thereof
SG11202108655TA (en) * 2019-02-15 2021-09-29 Univ Southern California Lym-1 and lym-2 antibody compositions and improved car constructs
WO2022085762A1 (en) * 2020-10-22 2022-04-28 富士フイルム株式会社 Reagent for measuring skin sensitization, compound, and method for measuring skin sensitization

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430943A1 (en) * 1978-07-13 1980-02-08 Toyo Jozo Kk NEW DISULFIDE DERIVATIVES
EP0040506B1 (en) * 1980-05-21 1986-08-20 Teijin Limited Reactive polymer and process for the preparation thereof
US4530835A (en) * 1983-07-08 1985-07-23 Warner-Lambert Company CL-1577 Antibiotic compounds and their production
CA1314245C (en) * 1984-05-23 1993-03-09 Franz Jansen Process for the preparation of conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, which are useful as immunotoxin potentiators
DE3588213T2 (en) * 1984-11-16 1999-09-30 American Cyanamid Co., Wayne Antitumor antibiotics (complex LL-E-33288)
EP0330874A3 (en) * 1988-02-29 1989-10-18 American Cyanamid Company Antibacterial and antitumor agents LL-E33288 epsilon-I and LL-E33288-epsilonBr, with processes and intermediates for producing said agents
EP0342341A3 (en) * 1988-05-17 1991-07-24 American Cyanamid Company Process for producing antitumor antibiotic ll-e33288gamma2

Also Published As

Publication number Publication date
DK602588D0 (en) 1988-10-28
NO173506C (en) 1993-12-22
AU2448988A (en) 1989-05-04
ES2061586T3 (en) 1994-12-16
FI95204B (en) 1995-09-29
FI95204C (en) 1996-01-10
NZ226726A (en) 1991-08-27
AU618763B2 (en) 1992-01-09
IL87946A0 (en) 1989-03-31
FI91262C (en) 1994-06-10
EP0313874A2 (en) 1989-05-03
KR890006244A (en) 1989-06-12
DK602488A (en) 1989-05-01
NO176480B (en) 1995-01-02
IL87947A0 (en) 1989-03-31
IE883261L (en) 1989-04-30
CA1321582C (en) 1993-08-24
IL87947A (en) 1995-05-26
FI884983A0 (en) 1988-10-28
HK131997A (en) 1997-10-03
PT88881B (en) 1993-01-29
AU612714B2 (en) 1991-07-18
BR1100939A (en) 1999-08-31
ATE104309T1 (en) 1994-04-15
IE883262L (en) 1989-04-30
KR970011385B1 (en) 1997-07-10
NZ226727A (en) 1991-12-23
AR246083A1 (en) 1994-03-30
AU2449488A (en) 1989-05-04
IE65989B1 (en) 1995-11-29
HK131897A (en) 1997-10-03
IE65053B1 (en) 1995-10-04
NO884834L (en) 1989-05-02
JP2720933B2 (en) 1998-03-04
DE3851682T2 (en) 1995-05-04
JP2820256B2 (en) 1998-11-05
DE3851682D1 (en) 1994-11-03
FI884984A0 (en) 1988-10-28
DE3889063T2 (en) 1994-12-01
DK602488D0 (en) 1988-10-28
JPH01193282A (en) 1989-08-03
DE3889063D1 (en) 1994-05-19
ES2059464T3 (en) 1994-11-16
NO173506B (en) 1993-09-13
IL87946A (en) 1995-06-29
ZA888123B (en) 1989-07-26
EP0313874A3 (en) 1990-05-09
ZA888127B (en) 1989-07-26
EP0313874B1 (en) 1994-04-13
FI884983A (en) 1989-05-01
NO176480C (en) 1995-04-12
KR890006245A (en) 1989-06-12
FI91262B (en) 1994-02-28
JPH0296599A (en) 1990-04-09
DK174739B1 (en) 2003-10-13
EP0313873B1 (en) 1994-09-28
FI884984A (en) 1989-05-01
DK602588A (en) 1989-05-01
PT88882B (en) 1993-01-29
NO884833L (en) 1989-05-02
NO884834D0 (en) 1988-10-28
EP0313873A1 (en) 1989-05-03
KR0133130B1 (en) 1998-04-17
ATE112172T1 (en) 1994-10-15

Similar Documents

Publication Publication Date Title
DE3886433D1 (en) Deodoriser.
ATA179188A (en) SPRAY CAMP
DE3869446D1 (en) DEODORIZING AGENT.
MX9203069A (en) SPONTANE VESTICULATION OF MULTILAMEL LIPOSOMES.
NO884833D0 (en) TARGETED FORMS OF METHYL TRITIO-ANTI-TUMOR AGENTS.
FI883761A0 (en) VATTENHALTIGA KOMPOSITIONER AV JONISKA TENSIDER MED FOERHOEJD VISKOSITET.
FI880803A (en) MASKIN FOER INLINDNING AV GODS MED STRAECKFOLIEBANA.
FI885342A0 (en) GASTURBIN MED LAENKINFAESTNING AV EN TAETNINGSRING I EN LEDSKOVELKRANS.
FI882084A (en) VALSPRESS MED EN ANORDNING FOER AVLASTNING AV EN BELASTNINGSVALS.
FI882862A0 (en) FOERFARANDE FOER MAERKNING AV EN LJUSVAOGSLEDARE MED FAERG.
FI880056A (en) FRAMSTAELLNING AV PLASTLEDNING MED SPAERREFFEKT.
FR2619009B1 (en) ANTI-HYPERLIPEMIC AGENT
ES2012433A4 (en) DECAFFEINIZATION OF AQUEOUS STRACTS.
NO884062D0 (en) DISINFECTION OF DEFORTS.
FR2654822B1 (en) DISPENSER OF SUB-PROJECTILES.
FI913285A (en) MEVINSYRADERIVAT OF SVAVELSUBSTITUERADE.
FI870397A (en) ANORDNING FOER FOERBAETTRING AV STYRBARHET I FORDON MED SVAENGBAR LARVMATTA.
DK629387D0 (en) COURSE OF ACTION
ES2010642B3 (en) ALKYL ESTERS OF L-ASPARTIL-3- (BICICLOALQUIL) -L-ALANINA.
FR2616660B1 (en) ANTIPLEPTIC AGENT
FI884614A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV CEFALOSPORINDERIVAT MED FOERBAETTRADE FARMAKOKINETISKA EGENSKAPER.
FI881870A (en) FOERFARANDE FOER FRAMSTAELLNING AV L-FENYLALANIN MED HJAELP AV REKOMBINANTBAKTERIER.
KR890700354A (en) Fragrance
KR890012275U (en) Cultivator cultivator
FI885167A0 (en) FOERFARANDE FOER SAENKNING AV MAENGDEN KVAEVEOXIDER I AVGASER MED ANVAENDNING AV HETEROCYKLISKT KOLVAETE.

Legal Events

Date Code Title Description
MK1K Patent expired